Voices
Naveen Pemmaraju

Naveen Pemmaraju: MECOM Fusion Partner and Bone Marrow Blast Percentage Influence Outcomes of Patients with MECOM

Naveen Pemmaraju, Professor of Department of Leukemia at MD Anderson Cancer Center, shared on X:

“Major new paper just out in BJH led by Dr Wei Ying Jen and Dr Tapan Kadia. MECOM fusion partner and bone marrow blast percentage influence outcomes of patients with MECOM -rearranged AML.”

Title: MECOM fusion partner and bone marrow blast percentage influence outcomes of patients with MECOM rearranged acute myeloid leukaemia

Authors: Wei-Ying Jen, Guilin Tang, Eitan Kugler, Jennifer Croden, Koji Sasaki, Alexandre Bazinet, Alex Bataller, Guillermo Montalban-Bravo, Gautam Borthakur, Gokce A. Toruner, Sanam Loghavi, Nicholas J. Short, Ghayas C. Issa, Ian M. Bouligny, Sherry Pierce, Uday Popat, Naveen Pemmaraju, Elias Jabbour, Guillermo Garcia-Manero, Kapil Bhalla, Farhad Ravandi, Naval G. Daver, Courtney D. DiNardo, Hagop M. Kantarjian, Tapan M. Kadia

Read the Full Article.

Naveen Pemmaraju: MECOM Fusion Partner and Bone Marrow Blast Percentage Influence Outcomes of Patients with MECOM

Alex Bataller Alexandre Bazinet cancer Courtney D. DiNardo Eitan Kugler Elias Jabbour Farhad Ravandi Gautam Borthakur Ghayas C. Issa Gokce A. Toruner Guilin Tang Guillermo Garcia-Manero Guillermo Montalban-Bravo Hagop M. Kantarjian Ian M. Bouligny Jennifer Croden Kapil Bhalla Koji Sasaki Naval G Daver Naveen Pemmaraju Nicholas J. Short OncoDaily Oncology Sanam Loghavi Sherry Pierce Tapan Kadia Tapan M. Kadia Uday Popat Wei Ying Jen